NCT06173011 2024-01-23
A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults
Qilu Pharmaceutical Co., Ltd.
Phase 1 Unknown
Clinical Trials
52 trialsNCT01481532 2024-01-17
Open Label Clinical Trial of Intravenous Crotoxin Part 3
Celtic Biotech Ltd
Phase 1 Unknown
NCT06175780 2023-12-26
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Phase 1 Unknown
NCT04987112 2023-12-22
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
CanWell Pharma Inc.
Phase 1 Unknown
NCT06087770 2023-12-18
Clinical Study of SM3321 With Solid Tumors
Beijing StarMab Biomed Technology Ltd
Phase 1 Unknown
NCT06147362 2023-11-27
68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study
Karolinska University Hospital
Phase 1 Unknown
NCT04343859 2023-11-09
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Tianjin Chasesun Pharmaceutical Co., LTD
Phase 1 Unknown
NCT06117371 2023-11-07
Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation
BeBetter Med Inc
Phase 1 Unknown
NCT06080984 2023-10-12
The Application of Novel Oncolytic Virus in Late Stage Solid Tumors
West China Hospital
Phase 1 Unknown
NCT05985083 2023-10-04
A Study Of IMM47 In Subjects With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Unknown
NCT03284502 2023-08-01
HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
Hanmi Pharmaceutical Company Limited
Phase 1 Unknown
NCT05769075 2023-04-24
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations
TYK Medicines, Inc
Phase 1 Unknown
NCT04787003 2023-03-23
Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors
North China Petroleum Bureau General Hospital
Phase 1 Unknown
NCT04900519 2023-01-17
Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors
Sorrento Therapeutics, Inc.
Phase 1 Unknown
NCT03774979 2022-11-08
SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT03491631 2022-11-04
Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT05552807 2022-09-23
SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sinocelltech Ltd.
Phase 1 Unknown
NCT05549557 2022-09-22
IMM40H Phase I Dose Escalation and Expansion
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Unknown
NCT04678908 2022-06-01
A Study of Injection HB0025 in Patients With Advanced Solid Tumors
Huabo Biopharm Co., Ltd.
Phase 1 Unknown
NCT04964375 2022-04-27
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor
Abbisko Therapeutics Co, Ltd
Phase 1 Unknown
NCT03646071 2022-04-13
A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors
NeuPharma, Inc.
Phase 1 Unknown
NCT05189717 2022-04-05
A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults
Shandong Suncadia Medicine Co., Ltd.
Phase 1 Unknown
NCT03835949 2022-04-01
Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer
Tracon Pharmaceuticals Inc.
Phase 1 Unknown
NCT05302843 2022-03-31
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
Betta Pharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT05238818 2022-02-14
Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors
Obstetrics & Gynecology Hospital of Fudan University
Phase 1 Unknown
NCT05200273 2022-01-20
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
Akeso
Phase 1 Unknown
NCT03710265 2021-11-22
SHR-1701 in Metastatic or Locally Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04973098 2021-11-04
Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma
Peking University
Phase 1 Unknown
NCT04859777 2021-09-16
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Monopteros Therapeutics Inc.
Phase 1 Unknown
NCT04674150 2021-08-16
GAMING
ALTality, Inc.
Phase 1 Unknown
NCT04979390 2021-07-28
Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04881981 2021-05-11
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
Baptist Health, Louisville
Phase 1 Unknown
NCT03986606 2020-11-25
A Study of PSB205 in Subjects With Advanced Solid Tumors
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Phase 1 Unknown
NCT02480036 2020-09-07
KYPHO-IORT
Loyola University
Phase 1 Unknown
NCT03468751 2020-06-01
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
Henlix, Inc
Phase 1 Unknown
NCT04087252 2020-04-15
An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment
Henan Cancer Hospital
Phase 1 Unknown
NCT01522989 2020-03-04
PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies
Georgetown University
Phase 1 Unknown
NCT04146610 2019-10-31
Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT03474289 2018-03-22
Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT03460457 2018-03-09
Tolerance and Pharmacokinetics of TQB2450
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT03453034 2018-03-05
Tolerance and Pharmacokinetics of TQ-B3233
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT02752516 2017-09-18
A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT02897986 2016-09-13
PROVIN
Assistance Publique Hopitaux De Marseille
Phase 1 Unknown
NCT02717741 2016-03-24
A Study of Tafetinib in Chinese Patients With Advanced Solid Tumor
Nanjing Yoko Biomedical Co., Ltd.
Phase 1 Unknown
NCT02044861 2015-06-23
Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies
Advanced Cancer Therapeutics
Phase 1 Unknown
NCT00688116 2014-09-18
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Synta Pharmaceuticals Corp.
Phase 1 Unknown
NCT01932177 2013-08-30
EVESOR
Hospices Civils de Lyon
Phase 1 Unknown
NCT00591292 2012-07-19
Phase I Study in Advanced Solid Tumors
Alaunos Therapeutics
Phase 1 Unknown
NCT00591383 2012-07-19
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
Alaunos Therapeutics
Phase 1 Unknown
NCT00591422 2012-07-19
Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas
Alaunos Therapeutics
Phase 1 Unknown